These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18833401)

  • 1. Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings.
    Mendes TM; Oliveira LC; Yamamoto L; Del Negro GM; Okay TS
    Braz J Infect Dis; 2008 Jun; 12(3):186-91. PubMed ID: 18833401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V; Kadi A; Mouna L; Fenaux H; Cechura H; Rafek R; Di Ciccone JL; Warnakulasuriya F; Vauloup-Fellous C
    J Virol Methods; 2024 Sep; 329():115002. PubMed ID: 39067186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
    Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
    Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection.
    Ding B; Zhang Y; Wu Y; Li Y
    J Med Virol; 2024 Oct; 96(10):e29960. PubMed ID: 39380297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical profile problem in serological diagnosis of EBV].
    Varıcı Balcı FK; Özbek ÖA; Sayıner AA
    Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.
    Huang Y; Wei C; Zheng K; Zhao D
    Virol J; 2013 Feb; 10():55. PubMed ID: 23406068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein-Barr infections in children with acute leukaemia. Preliminary report].
    Pawelec K; Trzcińska A; Siennicka J; Malinowska I; Litwińska B
    Med Wieku Rozwoj; 2008; 12(1):485-91. PubMed ID: 18663268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings.
    Iemura T; Kondo T; Hishizawa M; Yamashita K; Kimura H; Takaori-Kondo A
    Int J Infect Dis; 2019 Nov; 88():31-33. PubMed ID: 31398454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
    De Paschale M; Agrappi C; Manco MT; Mirri P; Viganò EF; Clerici P
    J Med Virol; 2009 Feb; 81(2):325-31. PubMed ID: 19107979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.